Her kan du lese mer om den forskningen som vi og våre søster-stiftelser i Sverige og Finland har vært med på å finansiere siden starten i 2008. Vi støtter både forskning innenfor diabetes typ1 og diabetes type 2.

Diabetes Wellness søker aktivt etter prosjekter som antas å ha de beste forutsetninger for å utvikle forbedrede behandlingsmåter eller å komme nærmere en endelig kur for diabetes.

Vår rådgivende komité vurderer mottatte søknader og gir sin anbefaling til styret, som fatter den endelige beslutningen.

Siden starten har Diabetes Wellness Sverige finansiert forskning for nærmere 100 millioner kroner, takket være de gavmilde menneskene som har valgt å støtte vårt arbeide.

Diabetes Wellness Norge er fortsatt relativt ung, og vi arbeider med å etablere en stabil base med støttespillere som kan hjelpe oss å finansiere forskning, både i Norge og utlandet.

Inntil videre kan du lese om noen av de prosjektene som vår svenske søsterorganisasjon har støttet.


Vil du være med og støtte forskningen?

Gjennom å støtte Diabetes Wellness Norge hjelper du oss i kampen mot diabetes. Din støtte bidrar ikke bare til å finansiere forskning på diabetes, men også til å informere allmennheten om sykdommen og dens mange farlige komplikasjoner.

Du hjelper oss ved å betale inn et valgfritt beløp til vår bankkonto 9046 12 86215. Husk at alle beløp er til nytte, og at ingen gave er for liten.

2022

Professor Sebastian Barg, Uppsala University

2 000 000 kroner

Paracrine control of islet hormone exocytosis in diabetes.

Professor Tore Bengtsson, Stockholm Universitet

2 000 000 kroner

Novel selectively targeted stimulation of the β2-adrenoceptor for the treatment of type 2 diabetes.

Dr Carolina Hagberg, Karolinska Institut

2 000 000 kroner

Can we prevent adipocyte dysfunction and metabolic disease via metabolic targeting of the adipose tissue?

Dr Benjamin King, Lund Universitet

2 000 000 kroner

Roles of splice isoform CD59-IRIS-1 in beta-cell identity and function.

Dr Olov Andersson, Karolinska Institut

2 000 000 kroner

Stimulating β-cell regeneration as a novel treatment of diabetes.

Dr Ingrid Wernstedt-Asterholm, Universitetet i Gøteborg

2 000 000 kroner

Collagenous Peptides in the Regulation of Adipose Tissue Remodelling.

2021

Professor Marcus Lind, Trollhättan

2 000 000 kroner

A randomized double-blind clinical trial comparing Hypochlorous Acid and Polyhexamethylene biguanide in treating diabetic foot ulcers.

Professor Olov Rolandsson, Universitetet i Umeå

1 000 690 kroner

Gastrointestinal adverse effects of metformin in treatment of type 2 diabetes - patients’ perspective and microbiota.

Professor Ulf Ahlgren, Universitetet i Umeå

2 000 000 kroner

High resolution optical 3D imaging to understand human diabetes pathophysiology in a whole organ context.

Dr Nicolas Pillon, Karolinska Institut

1 000 000 kroner

Regulation of glucose homeostasis in type 2 diabetes by eicosanoids.

Professor Nils Wierup, Lunds Universitet

2 000 000 kroner

Studies of T2D disease mechanisms in human islets.

Professor Eva Degerman, Lunds Universitet

316 000 kroner

The inner ear as a target for insulin action-implications for diabetes complications.

Professor Olga Göransson, Lunds Universitet

1 000 000 kroner

The role of amp-activated protein kinase in the regulation of fatty acid synthesis in adipocytes.

Professor Mia Phillipson, Uppsala Universitet

2 000 000 kroner

The role of immune cell-microbial interactions for long-term islet function and glucose homeostasis.

Professor Per-Ola Carlsson, Uppsala Universitet

2 000 000 kroner

Treat and prevent type 1 diabetes by mesenchymal stromal cells.

2020

Dr Olof Eriksson, Uppsala Universitet

1 303 200 SEK

GPR44 as a PET marker for measuring beta cell mass in human.

Professor Patrik Rorsman, Göteborgs Universitet

2 000 000 SEK

Pathophysiologycaemia risk in insulin-treated diabetes patients:more than the sum of the parts? Typ 1 diabetes.

Professor Anders Tengholm, Uppsala Universitet

2 000 000 SEK

Rap and Ras signalling in insulin secretion.

Dr Ingrid Wernstedt Asterholm, Göteborgs Universitet

2 000 000 SEK

Succinate-induced glucose uptake in skeletal muscle - a new therapeutic target for diabetes?

2019

Dr Alexander Hamilton, CRC Malmö

200 000 kroner

Arginase-2: The potential role of arginine metabolism in beta cell dysfunction.

Dr Marcus Lundberg, Uppsala Universitet

200 000 kroner

Examining acinar tissue of type 1 diabetes pancreata to elucidate the etiology of the disease.

Dr Amaya Lopez, Lunds Universitet

200 000 kroner

Functional validation of T2D dysregulated beta-cell gene regulatory networks.

Associate Professor Enming Zhang, Lunds Universitet

2 000 000 kroner

Improvement of diabetic beta cell functions using remotely controlled magnetic nanoparticles.

Professor Mia Phillipson, Uppsala Biomedisinske Senter

2 000 000 kroner

Neonatal infections alter islet maturation and long-term glucose homeostasis.

Professor Juleen R Zierath, Karolinska Institut

1 000 000 kroner

Reducing sedentary time to improve glucose and lipid metabolism.

Cecilia Morgantini, Karolinska Institut

200 000 kroner

Role and relevance of RNA editing of immune cells in obese-induced type 2 diabetes.

Professor Ulf Ahlgren, Umeå Universitet

1 000 000 kroner

The first absolute account of the islet mass distribution in the pancreas of healthy and diabetic individuals.

Professor John Pernow, Karolinska Institut

2 000 000 kroner

The importance of red blood cell dysfunction for cardiovascular complications in diabetes.

Dr Jonathan Cedernaes, Uppsala akademiske sykehus

200 000 kroner

Tissue-targeted circadian interventions for identifying genetic and molecular mechanisms regulating metabolic integrity in healthy and type 2 diabetic humans.

2018

Mr Fan Rongron, Karolinska Institut

200 000 kroner

Enhancer landscape remodelling during macrophage metaflammatory activation and its involvement in obesity induced metabolic disorder

Dr Katja Moller-Hackbarth, Karolinska Institut

200 000 kroner

Induced endothelial expression of podocyte specific Retinoic acid receptor responder1 (Rarres1) in Diabetic Kidney Disease (DKD) accelerates renal injury

Dr John Grunberg, Sahlgrenska, Universitetet i Gøteborg

200 000 kroner

Subcutaneous adipogenesis is a marker of future risk of Type 2 Diabetes – role of endothelial and precursor cell senescence

Dr Luis Rodrigo Cataldo, Lund Universitet

200 000 kroner

The novel MafA target gene PPP1R1A is modulating the GLP1R-amplifying glucose-stimulated insulin secretion

Dr Jones Ofori, Lund Universitet

200 000 kroner

Why do type-2 diabetic patients express less synaptotagmin 13 (SYT13) in their islets of Langerhans than healthy individuals?

2017

Dr. Mototsugu Nagao, Lunds Universitet

200 000 kroner

CD36 as a therapeutic target to improve beta cell function in type 2 diabetes

Dr. Oskar Skog, Uppsala Universitet

200 000 kroner

Characerization of the diabetic pancreas to unravel the pathogenesis and etiology of type 1 diabetes

Dr. Andreas Edsfeldt, Lunds Universitet

200 000 kroner

Diabetes associated vascular complications caused by impaired efferocytosis, inflammatory resolution and fibrotic tissue repair

Professor Nils Wierup, Lunds Universitet

2 000 000 lrpmer

Discovery and functional validation of regulatory networks in human pancreatic islets to identify targetable disease mechanisms underlying Type 2 diabetes

Dr. Emma Ahlqvist, Lund Universitet

1 981 000 kroner

How many diseases are type 2 diabetes? Confirmation, evaluation and implementation of a new diabetes subclassification

Dr. Evelina Vågesjö, Uppsala Universitet

200 000 kroner

Mechanisms in skin wound healing in non-diabetic and diabetic conditions and the effect of wound treatment with chemokines

Professor Lena Eliasson, Lund Universitet

2 000 000 kroner

Novel therapeutic tools and new biomarkers in diabetes with focus on islet specifik microRNAs

Dr Bernard Hering, University of Minnesota

850 000 kroner

Refining Immunosuppression to Prevent Rejection of Porcine Islet Xenografts

Dr. Abdul Waheed Khan, Karolinska Institut

200 000 kroner

Role of acetyltransferase GCN5 in endothelial oxidative stress in diabetes

Professor Per-Ola Carlsson, Uppsala Universitet

2 000 000 kroner

Translational studies of insulinsecreting cells derived from induced pluripotent stem cells

Dr Bernard Hering, University of Minnesota

167 000 USD

Spring Point Project, its mission is to provide an unlimited source of pig islet cells to accelerate the availability and affordability of islet transplantation to cure diabetes

2016

Dr Anna Nordström, Umeå universitet

1 000 000 kroner

6000 steps for better health – a randomised 12-month intervention study

Dr Anya Medina Benavente, Lunds Universitet

200 000 kroner

Autophagy in control of beta-cell mass and function in Type 2 Diabetes

Dr Luis Sarmiento, Lunds Universitet

200 000 kroner

Communication between virus-infected pancreatic beta-cells and the immune system: implication for Type 1 diabetes

Dr Jennifer Jager, Karolinska Institut

200 000 kroner

Contribution of genes and non-coding RNAs expressed by Kupffer cells in insulin resistance

Professor Fredrik Bäckhed, Universitetet i Gøteborg

2 000 000 kroner

Determining the microbiota in subjects with prediabetes

Dr Joan Domingo-Espin, Lunds universitet

200 000 kroner

Does Glycation of apoA-I links to higher risk of cardiovascular complications in diabetic patients?

Dr Midhat Abdulreda, Diabetes Research Institute Miami University

900 000 kroner

In collaboration with Prof. PO Berggren, Karolinska Institutet: Evaluating vision in the baboon following pancreatic islet transplantation in the eye anterior chamber

Dr Rashmi Prasad Bokkasa, Lunds universitet

200 000 kroner

Genetic and transcriptomic studies of fetal pancreas to understand fetal programming and development and identification of blood based biomarkers for pancreatic development

Professor Erik Renström, Lunds universitet

1 983 349 kroner

Growth differentiation factor 11 (GDF11) – a fons adolescentia for the pancreatic beta-cell that can delay or prevent onset of type 2 diabetes?

Dr Olof Lagerlöf, Karolinska Institut

1 938 350 kroner

Molecular control over a neuronal circuit that mediates feeding behaviour – and important new target in the fight against diabetes

Dr Bernard Hering, University of Minnesota

850 000 kroner

Refining Immunosuppression to Prevent Rejection of Porcine Islet Xenografts

Professor Eva Degerman, Lunds Universitet

346 000 kroner

Short chain fatty acids; gut metabolites with implications for metabolic health

Professor John Pernow, Karolinska Institut

1 000 000 kroner

The importance of endothelial and red blood cell dysfunction for vascular complications in type 2 diabetes

Professor Olle Korsgren, Uppsala universitet

1 800 000 kroner

The role of the duodenal microbiota in the etiopathology of Type 1 Diabetes

Dr Bernard Hering, University of Minnesota

167 000 USD

Spring Point Project, its mission is to provide an unlimited source of pig islet cells to accelerate the availability and affordability of islet transplantation to cure diabetes

2015

Per-Olof Berggren, Karolinska Institut

2 000 000 kroner

An in vivo approach to understand inositide signalling in the pancreatic beta cell

Anders Tengholm, Uppsala Universitet

1 000 000 kroner

Betydelsen av budbärarämnet cAMP för reglering av insulin- och glukagonfrisättningen

Peetra Magnusson, Uppsala Universitet

250 000 kroner

Cellular interactions of mesenchymal stromal cells in type 1 diabetes

Karin Stenkula, Lunds Universitet

250 000 kroner

Correlation between systemic insulin resistance and bimodal adipose cell response

Margit Mahlapuu, Universitetet i Gøteborg

925 000 kroner

En ny unik medisinsk behandling av type 2-diabetes basert på hemming av proteinkinaset STK25

Charlotte Ling, Lunds universitet

1 000 000 kroner

Hvordan påvirker fedme og diabetes type 2 funksjonen til stamcellene i musklene?

Olov Andersson, Karolinska Institut

1 000 000 kroner

Novel strategies for treating diabetes

Mia Phillipson, Uppsala Universitet

1 002 000 kroner

The role of pancreatic macrophages for development and maturation of islets of Langerhans and long-term metabolic control

Dariush Mokhtari, Uppsala adademiske sykehus

250 000 kroner

Tissue factor signaling in islets and beta-cells

Juleen Zierath och Anna Krook, Karolinska Institut

1 000 000 kroner

Träningsintervention vid metabola sjukdomar

Helena Edlund, Umeå Universitet

2 000 000 kroner

Typ 2 diabetes: en betacellsdegenerativ sjukdom?

Francesco Paneni, Karolinska Institut

250 000 kroner

Understanding redox signalling in diabetic cardiomyopathy: role of AP-1 transcription factor JunD

Ola Hansson, Lunds universitet

1 000 000 kroner

Vilken påverkan har ärftlighet på muskelegenskaper och metabolsjukdom? - funktionen av RAB3GAP2 och MAOA